As previously reported [15], [17], [18] retinoic acid treatment of several human neuroblastoma cells is rapidly followed by a strong increase in the expression of both these transmembrane receptors that become activated in the absence of exogenously added BDNF and GDNF ligands. This evidence concerns the gene NRP1 and neuroblastoma.